TrialSpark acquires immunodermatology portfolio and creates Libertas Bio
TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position…
November 30, 2022 - 3 minutes
News and Trends
bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases
Cell coding company bit.bio has made three additions to its product portfolio: ioGlutamatergic Neurons MAPT…
November 30, 2022 - 3 minutes
SOTIO exercises option on ADC program
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first…
November 30, 2022 - 2 minutes
AstraZeneca splashes out up to $320M on T-cell receptor therapy company
Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of…
November 30, 2022 - 3 minutes
Touchlight receives new grant to further develop doggybone DNA vaccine platform
UK-based biotechnology company, Touchlight, has received a new grant from the Bill & Melinda Gates…
November 29, 2022 - 2 minutes
Biocomposites antibiotic carrier, STIMULAN, receives approval for use in Mexico
UK-based medical devices company, Biocomposites Ltd., has announced that antibiotic carrier STIMULAN has received a…
November 29, 2022 - 2 minutes
Mycotechnology and IFF join forces in Europe to create better food system
Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership…
November 29, 2022 - 2 minutes
BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer…
November 29, 2022 - 2 minutes
Molecure to conduct cancer treatment trial in Poland
Molecure S.A. says the President of the Polish Office for Registration of Medicinal Products, Medical…
November 28, 2022 - 2 minutes
Deep Science Ventures and AbbVie to create companies to target inflammatory diseases
Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global…
November 28, 2022 - 2 minutes
Replay receives $1.5M grant for hypoimmunogenic technology platform
Genome writing company Replay has received a $1.56 million grant from the Bill & Melinda…
November 28, 2022 - 3 minutes
Localizing BRCA gene mutations to better treat ovarian cancer
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1…
November 28, 2022 - 5 minutes
